Psoriasis Stocks List

Psoriasis Stocks Recent News

Date Stock Title
May 9 VYNE VYNE Therapeutics GAAP EPS of -$0.15 beats by $0.09, revenue of $0.01M misses by $0.09M
May 9 CANF Can-Fite stock up on FDA IND clearance for namodenoson to treat MASH patients in mid-stage study
May 9 VYNE VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 ABBV Q1 2024 Regenxbio Inc Earnings Call
May 9 CANF Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
May 8 BIIB Jeff Auxier's Firm Dissolves Textainer Group Position, Trims Biogen
May 8 BIIB Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
May 8 ABBV QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
May 8 BIIB Q1 2024 Abcellera Biologics Inc Earnings Call
May 7 ABBV Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
May 7 ABBV 15 Best S&P 500 Dividend Stocks To Buy Now
May 6 ABBV 10 Best May Dividend Stocks To Buy
May 6 ABBV AbbVie to Present at the Bank of America Securities Healthcare Conference
May 6 VYNE VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
May 6 CANF Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602
May 5 ABBV 3 Reasons to Buy AbbVie Stock on the Dip
May 5 ROIV Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain
May 4 INCY Incyte First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 4 BIIB Morgan Stanley’s Top 15 Stock Picks for 2024
May 3 ABBV Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Psoriasis

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin the patches may be purple in colour. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors. In twin studies, identical twins are three times more likely to be affected compared to non-identical twins. This suggests that genetic factors predispose to psoriasis. Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs. Infections and psychological stress can also play a role. Psoriasis is not contagious. The underlying mechanism involves the immune system reacting to skin cells. Diagnosis is typically based on the signs and symptoms.There is no cure for psoriasis; however, various treatments can help control the symptoms. These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate. About 75 percent of cases can be managed with creams alone. The disease affects two to four percent of the population. Men and women are affected with equal frequency. The disease may begin at any age, but typically starts in adulthood. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn's disease and depression. Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.

Browse All Tags